EUVIMEDOpdag EUVIMED
Crossref

Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia

Avraham E Adelman iD, Advay Joshi, Kimberly Gallo, Aaron Prosser, Akash Mathavan, Akshay Mathavan, Ali Ataya, Jeb Justice

Otolaryngology–Head and Neck Surgery · 2026

DOI: 10.1002/ohn.70088 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, 2026. Written by Avraham E Adelman and 7 co-authors. Institution: Department of Otolaryngology-Head & Neck Surgery, University of Florida, Gainesville, Florida, USA. Major MEDLINE topics: Telangiectasia, Hereditary Hemorrhagic, Sclerotherapy, Vascular Malformations, Mouth Diseases. 5 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Oral telangiectasias in hereditary hemorrhagic telangiectasia (HHT) can significantly impair quality of life. While sclerotherapy is an established treatment for HHT‐related epistaxis, it is rarely used for oral telangiectasias. We retrospectively reviewed HHT patients who underwent oral sclerotherapy between 2021 and 2024 at a tertiary academic center. Eleven patients (64% female, mean age 61.3 years, 82% ACVRL1 genotype) underwent sclerotherapy using a 1:4 mixture of 3% sodium tetradecyl sulfate and air. Lesions treated included the lip (36%), tongue (36%), hard palate (18%), and gingiva (9%). Presenting symptoms included oral bleeding with eating and dietary limitations. Adverse effects included transient lip swelling (n = 2) and tongue burning (n = 1). At an average follow‐up of 6 months, 10/11 patients with follow‐up data had complete symptomatic and clinical resolution. Our findings suggest that oral sclerotherapy is a safe, effective, and minimally invasive treatment for HHT‐related oral bleeding that clinicians should consider.

Subjects

MeSH terms (MEDLINE)

Telangiectasia, Hereditary HemorrhagicSclerotherapyVascular MalformationsMouth DiseasesHumansFemaleMiddle AgedMaleRetrospective StudiesAgedSclerosing SolutionsAdultTreatment OutcomeSodium Tetradecyl Sulfate

Author keywords

HHTOsler‐Weber‐Rendu syndromeepistaxishereditary hemorrhagic telangiectasiaoral bleedingoral telangiectasiasclerotherapy

Substances

Sclerosing SolutionsSodium Tetradecyl Sulfate

Authors and institutions

  • Department of Otolaryngology-Head & Neck Surgery, University of Florida, Gainesville, Florida, USA.
  • Division of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Florida, Gainesville, Florida, USA.

ORCID profiles: Avraham E Adelman

Cite

APA

Adelman, A. E., Joshi, A., Gallo, K., Prosser, A., Mathavan, A., Mathavan, A., Ataya, A., & Justice, J. (2026). Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70088

Vancouver

Adelman AE, Joshi A, Gallo K, Prosser A, Mathavan A, Mathavan A, et al. Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70088

BibTeX
@article{Adelman2026,
  author = {Adelman, Avraham E and Joshi, Advay and Gallo, Kimberly and Prosser, Aaron and Mathavan, Akash and Mathavan, Akshay and Ataya, Ali and Justice, Jeb},
  title = {Role of Sclerotherapy in Treating Oral Vascular Malformations in Hereditary Hemorrhagic Telangiectasia},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2026},
  doi = {10.1002/ohn.70088}
}
Start for free →